Stay updated with breaking news from Generation Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Generation Bio Co. (NASDAQ:GBIO – Get Rating) saw a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 1,430,000 shares, an increase of 10.0% from the February 28th total of 1,300,000 shares. Based on an average daily trading volume, of 458,900 shares, the short-interest ratio […]
Generation Bio Co. (NASDAQ:GBIO – Get Rating) – William Blair issued their Q1 2023 EPS estimates for shares of Generation Bio in a report issued on Wednesday, March 22nd. William Blair analyst M. Minter anticipates that the company will post earnings per share of ($0.60) for the quarter. William Blair currently has a “Market Perform” […]
Needham & Company LLC reiterated their buy rating on shares of Generation Bio (NASDAQ:GBIO – Get Rating) in a research note published on Thursday morning, Benzinga reports. The brokerage currently has a $14.00 price target on the stock. Separately, JMP Securities lowered their price objective on Generation Bio from $7.00 to $2.23 and set a […]
Needham & Company LLC reiterated their buy rating on shares of Generation Bio (NASDAQ:GBIO – Get Rating) in a report published on Thursday, Benzinga reports. The brokerage currently has a $14.00 price target on the stock. Separately, JMP Securities decreased their price target on shares of Generation Bio from $7.00 to $2.23 and set a […]
In a late stage trial Dupixent, jointly developed with Regeneron, led to a 30% reduction in moderate or severe acute exacerbations of chronic obstructive pulmonary disease (COPD), a potentially deadly disease marked by progressive lung function decline. Masimo CEO waives right to $600 million payout in fight with activist investor Masimo Corp Chief Executive Joe Kiani has waived his rights for roughly $600 million in special payment if the U.S. medical device maker appoints a lead independent director, the company said on Thursday.